Lay Summary We present a case series of 16 patients with ulcerative colitis who received upadacitinib after failing tofacitinib. Five patients (36%) achieved steroid-free clinical remission. Five (62%) demonstrated endoscopic response, while 2 patients (25%) achieved endoscopic remission. Adverse events were low.
No takes yet. Share an insight, caveat, or question.
Levine et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: